Objective: In this hypothesis-testing study, which is based on findings from a previous atheoretical machine-learning study, we test the predictive power of baseline “reduced expression of emotion” for psychosis. Method: Study participants (N = 96, mean age 16.55 years) were recruited from the Prevention of Psychosis Study in Rogaland, Norway. The Structured Interview for Prodromal Syndromes (SIPS) was conducted 13 times over two years. Reduced expression of emotion was added to positive symptoms at baseline (P1–P5) as a predictor of psychosis onset over a two-year period using logistic regression. Results: Participants with a score above zero on expression of emotion had over eight times the odds of conversion (OR = 8.69, p < .001). ...
Recent research has started to focus on identifying individuals who are at clinical high risk of dev...
Twenty percent of individuals at clinical high risk for psychosis (CHR-P) develop the disorder withi...
BackgroundTransition to psychosis is among the most adverse outcomes of clinical high-risk (CHR) syn...
Objective: In this hypothesis-testing study, which is based on findings from a previous atheoretical...
Aim: The fluctuating symptoms of clinical high risk for psychosis hamper conversion prediction model...
Aim The fluctuating symptoms of clinical high risk for psychosis hamper conversion prediction model...
Importance: The development of adverse clinical outcomes in patients with psychosis has been associa...
Objectives: Most individuals experience a relatively long period of sub-clinical psychotic like symp...
Objectives: Most individuals experience a relatively long period of sub-clinical psychotic like symp...
To investigate the impact of expressed emotion (EE) on the risk of developing the first psychotic ep...
This case-control study analyzes emotion recognition and neuroimaging data as well as clinical and f...
Objective: To investigate the impact of expressed emotion (EE) on the risk of developing the first p...
INTRODUCTION: A barrier to preventative treatments for psychosis is the absence of accurate identifi...
Background: Transition to psychosis is among the most adverse outcomes of clinical high-risk (CHR) s...
Recent research has started to focus on identifying individuals who are at clinical high risk of dev...
Twenty percent of individuals at clinical high risk for psychosis (CHR-P) develop the disorder withi...
BackgroundTransition to psychosis is among the most adverse outcomes of clinical high-risk (CHR) syn...
Objective: In this hypothesis-testing study, which is based on findings from a previous atheoretical...
Aim: The fluctuating symptoms of clinical high risk for psychosis hamper conversion prediction model...
Aim The fluctuating symptoms of clinical high risk for psychosis hamper conversion prediction model...
Importance: The development of adverse clinical outcomes in patients with psychosis has been associa...
Objectives: Most individuals experience a relatively long period of sub-clinical psychotic like symp...
Objectives: Most individuals experience a relatively long period of sub-clinical psychotic like symp...
To investigate the impact of expressed emotion (EE) on the risk of developing the first psychotic ep...
This case-control study analyzes emotion recognition and neuroimaging data as well as clinical and f...
Objective: To investigate the impact of expressed emotion (EE) on the risk of developing the first p...
INTRODUCTION: A barrier to preventative treatments for psychosis is the absence of accurate identifi...
Background: Transition to psychosis is among the most adverse outcomes of clinical high-risk (CHR) s...
Recent research has started to focus on identifying individuals who are at clinical high risk of dev...
Twenty percent of individuals at clinical high risk for psychosis (CHR-P) develop the disorder withi...
BackgroundTransition to psychosis is among the most adverse outcomes of clinical high-risk (CHR) syn...